The Pharmaceutical Journal
Vol 269 No 7226 p770
30 November 2002

This article
Reprint
Photocopy

News summary

New BCG vaccine

A new BCG (tuberculosis) vaccine (BCG vaccine SSI) has been launched this week by Danish company Staten Serum Institut (see p776). The launch follows the recall of all batches of BCG vaccine manufactured by Evans Vaccines (PJ, 5 October, p470).

The dose of BCG vaccine SSI for children aged 12 months and older is 0.1ml by intradermal injection, whereas the same dose of the Evans BCG vaccine was for children aged three months and older. Children under 12 months should be given 0.05ml of BCG vaccine SSI. A percutaneous preparation of BCG vaccine SSI for use by the multiple puncture technique has not been produced.